跳至主要内容
临床试验/NCT00683657
NCT00683657已完成3 期

A 4-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial To Evaluate The Efficacy And Safety Of Saxagliptin In Comparison To Placebo As Add On Treatment To Metformin XR In Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet And Exercise And A Stable Dose Of Metformin ≥1500 mg/Day

AstraZeneca14 个研究点 分布在 2 个国家目标入组 93 人开始时间: 2008年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
AstraZeneca
入组人数
93
试验地点
14
主要终点
Change From Baseline in 24-Hour Mean Weighted Glucose (MWG) at Week 4

研究概览

简要总结

This protocol will compare 24 hour glucose control for subject taking saxagliptin and metformin extended release (XR) versus metformin XR alone

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 77 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18- and ≤77-years-old
  • Type 2 diabetes
  • Taking metformin immediate release (IR) or XR ≥1500 mg for at least 8 weeks as monotherapy
  • Glycosylated hemoglobin (A1C) ≥7% and ≤10%
  • Body mass index (BMI) ≤40 kg/m2

排除标准

  • Women of childbearing potential unable or unwilling to use acceptable birth control
  • Women who are pregnant or breastfeeding
  • Significant cardiovascular history
  • Active liver disease
  • Renal impairment

研究组 & 干预措施

Saxagliptin 5 mg + Metformin

Experimental

干预措施: Saxagliptin (Drug)

Placebo + Metformin

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Change From Baseline in 24-Hour Mean Weighted Glucose (MWG) at Week 4

时间窗: Baseline, Week 4

Adjusted mean change from baseline in MWG achieved with saxagliptin 5 mg plus metformin XR versus placebo plus metformin XR at Week 24. MWG was calculated as the area under the curve (AUC) for the full 24 hours expressed as average mg/dL. Glucose measurements were collected 30 minutes before and just prior to each meal (0 minutes) and 30, 60, 120, and 180 minutes after each meal (with 1 additional measurement at 240 minutes after the evening meal), midnight, 3 AM, and at end-of-domicile visit 24 hours after the first measurement. Mean change from baseline was adjusted for baseline value.

次要结局

  • Change From Baseline in 4-Hour Mean Weighted Postprandial Plasma Glucose at Week 4(Baseline, Week 4)
  • Change From Baseline in 2-Hour Postprandial Plasma Glucose After the Evening Meal at Week 4(Baseline, Week 4)
  • Change From Baseline in Mean Daily Glucose at Week 4(Baseline, Week 4)
  • Change From Baseline in 2-Day Average Fasting Plasma Glucose (FPG) at Week 4(Baseline, Week 4)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验